SLC5A2 and hydrops fetalis: Therefore, understanding the factors that affect the efficacy of SGLT2 inhibitors in the context of HF post-AMI was critical for optimizing therapeutic outcomes and guiding personalized treatment strategies (Liang et al., 2023).